These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21316770)

  • 1. Rewiring the brain with cell transplantation in Parkinson's disease.
    Gaillard A; Jaber M
    Trends Neurosci; 2011 Mar; 34(3):124-33. PubMed ID: 21316770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.
    Björklund LM; Isacson O
    Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-based therapies for Parkinson's disease.
    Dyson SC; Barker RA
    Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell transplantation for Parkinson's disease: present status.
    Drucker-Colín R; Verdugo-Díaz L
    Cell Mol Neurobiol; 2004 Jun; 24(3):301-16. PubMed ID: 15206816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural stem cells and transplantation studies in Parkinson's disease.
    Pardal R; López-Barneo J
    Adv Exp Med Biol; 2012; 741():206-16. PubMed ID: 22457112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease.
    Armstrong RJ; Hurelbrink CB; Tyers P; Ratcliffe EL; Richards A; Dunnett SB; Rosser AE; Barker RA
    Exp Neurol; 2002 May; 175(1):98-111. PubMed ID: 12009763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transplantation in Parkinson's disease: problems and perspectives.
    Allan LE; Petit GH; Brundin P
    Curr Opin Neurol; 2010 Aug; 23(4):426-32. PubMed ID: 20489615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell transplantation: a promising therapy for Parkinson's disease.
    Wang Y; Chen S; Yang D; Le WD
    J Neuroimmune Pharmacol; 2007 Sep; 2(3):243-50. PubMed ID: 18040857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic dopaminergic progenitor cells from En1(+/Otx2lacZ) transgenic mice survive and functionally reinnervate the striatum following transplantation in a rat model of Parkinson's disease.
    Hackl C; Papazoglou A; Ganser C; Klein A; Prakash N; Wurst W; Nikkhah G
    Cell Transplant; 2010; 19(9):1085-101. PubMed ID: 20447348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.
    Struzyna LA; Browne KD; Brodnik ZD; Burrell JC; Harris JP; Chen HI; Wolf JA; Panzer KV; Lim J; Duda JE; España RA; Cullen DK
    J Tissue Eng Regen Med; 2018 Jul; 12(7):1702-1716. PubMed ID: 29766664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.
    Yasuhara T; Matsukawa N; Hara K; Yu G; Xu L; Maki M; Kim SU; Borlongan CV
    J Neurosci; 2006 Nov; 26(48):12497-511. PubMed ID: 17135412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.